Triatec and Pericarditis - a phase IV clinical study of FDA data

Summary:

Pericarditis is reported as a side effect among people who take Triatec (ramipril), especially for people who are female, 60+ old, also take Lantus, and have Pain.

The phase IV clinical study analyzes which people have Pericarditis when taking Triatec. It is created by eHealthMe based on reports of 4,124 people who have side effects when taking Triatec from the FDA, and is updated regularly.

What is Triatec?

Triatec has active ingredients of ramipril. eHealthMe is studying from 4,133 Triatec users. Check the latest studies of Triatec.

What is Pericarditis?

Pericarditis (inflammation of the pericardium) is found to be associated with 861 drugs and 941 conditions by eHealthMe. Check the latest studies of Pericarditis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

4,124 people reported to have side effects when taking Triatec.
Among them, 15 people (0.36%) have Pericarditis.

Among these 15 people:

What is the gender of people who have Pericarditis when taking Triatec? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Pericarditis when taking Triatec? *

What are other drugs people take besides Triatec? *

What are other side effects people have besides Pericarditis? *

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 9 people, 60.00%
Speech Impairment (Adult) (inability to speak (adult)): 7 people, 46.67%
Red Blood Cell Count Decreased: 7 people, 46.67%
Morganella Infection (infection by morganella morganii bacteria): 5 people, 33.33%
Joint Pain: 5 people, 33.33%
Oedema Peripheral (superficial swelling): 5 people, 33.33%
Pain In Extremity: 5 people, 33.33%
Escherichia Infection (bacterial infection by escherichia coli): 5 people, 33.33%
Pleural Effusion (water on the lungs): 5 people, 33.33%
Diarrhea: 5 people, 33.33%

What are the existing conditions these people have? *

Pain: 12 people, 80.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 53.33%
Insomnia (sleeplessness): 7 people, 46.67%
High Blood Pressure: 7 people, 46.67%
Diabetes: 7 people, 46.67%
Depression: 7 people, 46.67%
Constipation: 7 people, 46.67%
Cardiac Disorder: 7 people, 46.67%
Multiple Myeloma (cancer of the plasma cells): 5 people, 33.33%
Osteitis (a general term for inflammation of bone): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Triatec and have Pericarditis?

- Check whether Pericarditis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Triatec:

Triatec (4,133 reports)

Pericarditis treatments and more:

Pericarditis (18,666 reports)

Browse all side effects of Triatec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pericarditis:

Pericarditis (861 drugs)

Browse all the conditions that are associated with Pericarditis:

Pericarditis (941 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ramipril (the active ingredients of Triatec) and Triatec (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.